ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 163 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,000 | -33.3% | 55 | -1.8% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 56 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 56 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $3,000 | +50.0% | 56 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -33.3% | 56 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $3,000 | -75.0% | 56 | -87.7% | 0.00% | -66.7% |
Q3 2017 | $12,000 | -99.8% | 456 | -2.1% | 0.00% | +50.0% |
Q2 2017 | $8,000,000 | – | 466 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |